Northeast Pharmaceutical Group (SZSE:000597) Jumps 6.7% This Week, Though Earnings Growth Is Still Tracking Behind Five-year Shareholder Returns

Simply Wall StDec 2 21:39 ET

Market Might Still Lack Some Conviction On Northeast Pharmaceutical Group Co., Ltd. (SZSE:000597) Even After 27% Share Price Boost

Simply Wall StNov 8 17:19 ET

Northeast Pharmaceutical Group Acquiring 70% Stake in Dingcheng Peptide Source; Shares Up 10%

MT NewswiresNov 6 01:40 ET

Northeast Pharmaceutical Group's (SZSE:000597) Shareholders Have More To Worry About Than Only Soft Earnings

Simply Wall StOct 30 18:07 ET

Tohoku Pharmaceutical: Report for the third quarter of 2024

SZSIOct 23 12:00 ET · Announcements

Northeast Pharmaceutical Group (000597.SZ): The net income in the first three quarters is approximately 0.208 billion yuan, a decrease of 5.37% year-on-year.

Gelonghui, October 23 - Northeast Pharmaceutical Group (000597.SZ) announced that the revenue in the first three quarters of 2024 was approximately 6.134 billion yuan, a decrease of 4.22% year-on-year; the net income attributable to shareholders of the listed company was approximately 0.208 billion yuan, a decrease of 5.37% year-on-year; and the basic earnings per share was 0.1455 yuan.

Gelonghui FinanceOct 23 08:30 ET